← Back to Clinical Trials
Recruiting NCT07109752

NCT07109752 Effect of eHealth Cardiac Rehabilitation Incorporating Mindfulness for Patients With Coronary Heart Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07109752
Status Recruiting
Phase
Sponsor Tung Wah College
Condition Coronary Heart Disease (CHD)
Study Type INTERVENTIONAL
Enrollment 146 participants
Start Date 2024-07-20
Primary Completion 2026-01-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
eHealth cardiac rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 146 participants in total. It began in 2024-07-20 with a primary completion date of 2026-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

People with coronary heart disease (CHD) often feel more stressed, which can increase the risk of having another heart problem. Cardiac rehabilitation (CR) is a common treatment for those with CHD, focusing on changing lifestyles and managing the disease. However, it often does not address stress management adequately. There is also a lack of psychological therapy and involvement of mental health professionals in online CR programs. Because traditional CR programs have low participation rates, online platforms are becoming more popular for providing rehabilitation support. This is important because more than half of people with CHD report high stress levels, which can cause or worsen heart problems. To address this issue, the proposed study will test an online CR program that includes mindfulness to help manage stress for CHD patients.

Eligibility Criteria

Inclusion Criteria: People will be eligible for this study if they were: 1. diagnosed with CHD (within the past 6 months), 2. undergone conservative treatment, such as percutaneous coronary intervention (PCI) and/ or medication, 3. currently under stable medication regimen and discharged to home. 4. aged 18 years or older, 5. reported scores ranging from 3 (to some degree) to 5 (very much) scores on a single-item stress symptoms scale (Elo et al., 2003), 6. using a computer and/or smartphone to access the Internet at home, 7. and, read and speak Chinese. Exclusion Criteria: 1. diagnosis of acute psychotic disease; 2. presence of a life-limiting condition; 3. prescribed contradictions to physical activity; and, 4. presence of hearing, visual, or ambulatory disorders

Contact & Investigator

Central Contact

Jingjing Su, PhD

✉ jjsu@twc.edu.hk

📞 852-37256115

Frequently Asked Questions

Who can join the NCT07109752 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Heart Disease (CHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07109752 currently recruiting?

Yes, NCT07109752 is actively recruiting participants. Contact the research team at jjsu@twc.edu.hk for enrollment information.

Where is the NCT07109752 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT07109752 clinical trial?

NCT07109752 is sponsored by Tung Wah College. The trial plans to enroll 146 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology